These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 8012985
1. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Xu XC, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. Cancer Res; 1994 Jul 01; 54(13):3580-7. PubMed ID: 8012985 [Abstract] [Full Text] [Related]
2. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. Lotan R. Anticancer Res; 1996 Jul 01; 16(4C):2415-9. PubMed ID: 8816844 [Abstract] [Full Text] [Related]
3. Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization. Jiang SY, Shen SR, Shyu RY, Yu JC, Harn HJ, Yeh MY, Lee MM, Chang YC. Br J Cancer; 1999 Apr 01; 80(1-2):206-14. PubMed ID: 10389997 [Abstract] [Full Text] [Related]
4. Expression of retinoic acid receptors in squamous cell carcinomas and their possible implication for chemoprevention. Issing WJ, Wustrow TP. Anticancer Res; 1996 Apr 01; 16(4C):2373-7. PubMed ID: 8816837 [Abstract] [Full Text] [Related]
5. Suppression of squamous cell carcinoma growth and differentiation by retinoids. Lotan R. Cancer Res; 1994 Apr 01; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325 [Abstract] [Full Text] [Related]
6. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, Heyman RA, Chandraratna RA, Shudo K, Hong WK, Lotan R. Clin Cancer Res; 2000 Apr 01; 6(4):1563-73. PubMed ID: 10778990 [Abstract] [Full Text] [Related]
7. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Xu XC, Wong WY, Goldberg L, Baer SC, Wolf JE, Ramsdell WM, Alberts DS, Lippman SM, Lotan R. Cancer Res; 2001 Jun 01; 61(11):4306-10. PubMed ID: 11389049 [Abstract] [Full Text] [Related]
8. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. Xu XC, Sozzi G, Lee JS, Lee JJ, Pastorino U, Pilotti S, Kurie JM, Hong WK, Lotan R. J Natl Cancer Inst; 1997 May 07; 89(9):624-9. PubMed ID: 9150186 [Abstract] [Full Text] [Related]
9. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Zou CP, Clifford JL, Xu XC, Sacks PG, Chambon P, Hong WK, Lotan R. Cancer Res; 1994 Oct 15; 54(20):5479-87. PubMed ID: 7522960 [Abstract] [Full Text] [Related]
10. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R. Cancer Res; 1997 Nov 15; 57(22):4992-6. PubMed ID: 9371489 [Abstract] [Full Text] [Related]
11. Expression of retinoid receptors in sebaceous cell carcinoma. Chakravarti N, El-Naggar AK, Lotan R, Anderson J, Diwan AH, Saadati HG, Diba R, Prieto VG, Esmaeli B. J Cutan Pathol; 2006 Jan 15; 33(1):10-7. PubMed ID: 16441406 [Abstract] [Full Text] [Related]
12. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Widschwendter M, Berger J, Daxenbichler G, Müller-Holzner E, Widschwendter A, Mayr A, Marth C, Zeimet AG. Cancer Res; 1997 Oct 01; 57(19):4158-61. PubMed ID: 9331065 [Abstract] [Full Text] [Related]
13. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK. N Engl J Med; 1995 May 25; 332(21):1405-10. PubMed ID: 7723796 [Abstract] [Full Text] [Related]
14. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH, De Luca LM. Cancer Res; 1995 Jul 01; 55(13):2774-82. PubMed ID: 7540949 [Abstract] [Full Text] [Related]
15. Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis. Xu XC, Lee JS, Lippman SM, Ro JY, Hong WK, Lotan R. Cancer Epidemiol Biomarkers Prev; 1995 Dec 01; 4(8):871-6. PubMed ID: 8634660 [Abstract] [Full Text] [Related]
16. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention. Shin DM, Xu XC, Lippman SM, Lee JJ, Lee JS, Batsakis JG, Ro JY, Martin JW, Hittelman WN, Lotan R, Hong WK. Clin Cancer Res; 1997 Jun 01; 3(6):875-80. PubMed ID: 9815762 [Abstract] [Full Text] [Related]
17. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age. Olasz J, Juhász A, Remenár E, Engi H, Bak M, Csuka O, Kásler M. Oncol Rep; 2007 Jul 01; 18(1):105-12. PubMed ID: 17549354 [Abstract] [Full Text] [Related]
18. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids. Agarwal C, Chandraratna RA, Teng M, Nagpal S, Rorke EA, Eckert RL. Cell Growth Differ; 1996 Apr 01; 7(4):521-30. PubMed ID: 9052993 [Abstract] [Full Text] [Related]
19. [Expression of retinoic acid receptors in head and neck squamous cell carcinomas and their possible implication for chemoprevention]. Issing WJ. Laryngorhinootologie; 2001 Sep 01; 80(9):530-4. PubMed ID: 11555786 [Abstract] [Full Text] [Related]
20. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor. Lawrence JA, Merino MJ, Simpson JF, Manrow RE, Page DL, Steeg PS. Cancer Epidemiol Biomarkers Prev; 1998 Jan 01; 7(1):29-35. PubMed ID: 9456240 [Abstract] [Full Text] [Related] Page: [Next] [New Search]